Cognitive Adaptations to Reduce Emotional Stress Associated With Type 1 Diabetes
| Status: | Recruiting |
|---|---|
| Conditions: | Diabetes, Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 5 - 12 |
| Updated: | 3/15/2019 |
| Start Date: | January 20, 2019 |
| End Date: | July 2020 |
| Contact: | Susana R Patton, PhD, CDE |
| Email: | spatton2@kumc.edu |
| Phone: | 913-588-6323 |
Longitudinal Test of Adherence & Control in Kids New to Type 1 Diabetes & 5-9 Years Old
The purpose of this study is to evaluate a new intervention (CARES: Cognitive Adaptations to
Reduce Emotional Stress Associated with Type 1 Diabetes) designed to reduce caregiver
depressive symptoms in families of children with T1D. This is a pilot, single-arm study, in
which all enrolled parents/caregivers will be placed in the intervention group to assess
initial pre- to post-treatment impact of the intervention on parent/caregiver depression,
distress, and diabetes-related outcomes (e.g., glycemic control).
Reduce Emotional Stress Associated with Type 1 Diabetes) designed to reduce caregiver
depressive symptoms in families of children with T1D. This is a pilot, single-arm study, in
which all enrolled parents/caregivers will be placed in the intervention group to assess
initial pre- to post-treatment impact of the intervention on parent/caregiver depression,
distress, and diabetes-related outcomes (e.g., glycemic control).
Inclusion Criteria:
- Parent/primary caregiver of a child diagnosed with T1D between 5-12 years old
- Parent/caregiver elevated depression symptoms on the CESD-R (score ≥ 16 at time of
screening)
- Child with T1D receiving intensive insulin regimen by multiple dose injections (MDI)
or continuous subcutaneous insulin infusion (pump)
Exclusion Criteria:
- Child with T1D currently in foster care or not living with legal guardian
- Child with evidence of type 2 diabetes or monogenic diabetes
- Child with a co-morbid chronic illness (e.g., renal disease) that requires ongoing
care beyond T1D
- Children who are chronically using medications that may impact glycemic control (i.e.,
systemic steroids)
- Parents/caregivers who do not speak English (currently there is no way to recruit
non-English speaking families because the study questionnaires are only available in
English)
We found this trial at
1
site
2401 Gillham Rd
Kansas City, Missouri 64108
Kansas City, Missouri 64108
(816) 234-3000
Principal Investigator: Mark Clements, MD
Phone: 816-234-3000
Children's Mercy Hospital Children's Mercy Hospitals and Clinics continues redefining pediatric medicine throughout the Midwest...
Click here to add this to my saved trials
